About Rahm Sensor Development Inc

Rahm Sensor Development is building the infrastructure for real-time human-state intelligence. The company uses a proprietary fusion of radar, thermal imaging, and AI to continuously monitor vital signs and behavior without wearables or direct contact. Its flagship product, Cell-Guardian, is already deployed in correctional facilities—one of the highest-liability environments—where it detects medical distress and behavioral risk in real time. Rahm is expanding this platform into elder care and healthcare, creating a scalable system for continuous, non-invasive human monitoring

Tagged with

Healthcare Internet of Things (IoT) Computer Vision & Image Processing Artificial Intelligence Security & Public Safety

Team

Vik Ramprakash

Founder

Problem statement

Today’s monitoring systems fail to detect early signs of medical distress and high-risk behavior. Cameras rely on visibility and human observation, while wearables depend on compliance and are often removed or unavailable. In high-liability environments like correctional facilities and elder care, this leads to missed events, delayed response, and significant legal and operational risk. The market needs continuous, non-contact monitoring that can understand a person’s physiological state in real time

Traction Metrics

Traction information

Rahm is generating early commercial traction in U.S. correctional facilities, with live deployments across 8 counties (~40 units installed) and approximately $250K in signed purchase orders. Our active pipeline is ~$2.0M, with additional deployments underway in Q2 2026, including LA County, Wyandotte County, and Christian County.

Product video

Product images

Milestones

January 2026

Early Pilot Deployment of Silver-Guardian

Initiated the first Silver-Guardian pilot at 7 Acres (Cincinnati) in January 2026, marking entry into elder care and validating real-world deployment outside of corrections.

October 2025

Silver-Guardian Registered as FDA Class 1 Device

Silver-Guardian is registered as an FDA Class I medical device, enabling initial commercial deployment and establishing the regulatory pathway toward Class II (510(k)) clearance.

September 2025

Cell-Guardian 1st PO

Received the first commercial purchase order for Cell-Guardian, marking the transition from pilot deployment to revenue-generating customer adoption.

May 2025

Cell-Guardian Registered as FDA Class I device

Cell-Guardian is registered as an FDA Class I medical device, enabling commercial deployment while establishing a regulatory pathway toward Class II (510(k)) clearance

January 2025

Early Pilot Deployment of Cell-Guardian

Installed our first Cell-Guardian system as a pilot in Nelson County, Kentucky, marking the transition from development to real-world validation in a live correctional environment

Updates

Profile created.

Added about 3 hours ago

Funding

Currently raising capital

committed

$4,000,000

round goal

Total raised to date: $1,500,000